chapter  1
-Death receptors in apoptosis 27
7.3 Targeting death receptors for treatment of cancers
Pages 4

ATRA is followed by the emergence of ATRA-resistant disease, it will be interesting to determine whether ATRA-resistant APL cells can be treated by inhibition of NFkB and/or administration of Apo2L/TRAIL.